Search Within

Nursing

  1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Meeting Abstract (99)
  2. Journal Article (86)
  3. Conference Paper (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (189)
  2. Department of Medicine (162)
  3. Solid Tumor Oncology Division (134)
  4. GSK Faculty (124)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (83)
  6. Survivorship Research (80)

More Groups

People
  1. Larry Norton (52)
  2. Clifford Hudis (44)
  3. Paul Chapman (38)
  4. Jedd Wolchok (32)
  5. David Scheinberg (30)
  6. Katherine Panageas (26)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Blood (18)
  3. Clinical Cancer Research (17)
  4. Cancer Research (10)
  5. Neuro-Oncology (10)
  6. Pediatric Blood and Cancer (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (56)
  2. American Association for Cancer Research (33)
  3. American Society of Hematology (19)
  4. Oxford University Press (16)
  5. Elsevier Inc. (11)
  6. Springer (6)

More Publishers

Results (189)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma
    Journal Article

    Souweidane, M. M.; Bander, E. D.; Zanzonico, P.; Reiner, A. S.; Manino, N.; Haque, S.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Lewis, J. S.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
    Meeting Abstract

    Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • The ARETHA study: A phase 2 randomized control trial of eribulin with evexomostat (SDX-7320) or placebo for patients with metastatic triple-negative breast cancer (TNBC) and metabolic dysfunction
    Meeting Abstract

    Shen, S.; Solomon, V.; Williams, D.; Robson, M. E.; Norton, L.; Traina, T. A.; Iyengar, N. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save